trimethoprim has been researched along with E coli Infections in 222 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a prospective randomized study 38 patients with recurrent urinary tract infections (rUTI) were included to take either 50 mg Nitrofurantoin (n = 19) or 50 mg Trimethoprim (n = 19) as low-dose long-term prophylaxis for half a year." | 9.07 | Nitrofurantoin versus trimethoprim for low-dose long-term prophylaxis in patients with recurrent urinary tract infections. A prospective randomized study. ( Vahlensieck, W; Westenfelder, M, 1992) |
| "Two-hundred nine patients with symptoms of acute urinary tract infection and pyuria were randomized to 400 mg of administered norfloxacin twice daily for three days, or 800 mg of sulfamethoxazole and 160 mg of trimethoprim administered twice daily for ten days." | 9.06 | A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections. ( Boyko, EJ; Cox, CE; Goldstein, EJ; Kurtz, TO; Miller, K; Mummaw, N; Reller, LB; Stein, GE, 1987) |
| "A single dose of 100 mg ofloxacin was compared with a multiple dose of cotrimoxazole in lower urinary tract infections in 137 women." | 9.06 | Failure of a single dose of 100 mg ofloxacin in lower urinary tract infections in females. ( Forsgren, A; Ode, B; Walder, M, 1987) |
| "Single-dose trimethoprim treatment of cystitis was compared with 7-day treatment in a randomized double-blind study in primary health care." | 9.06 | Efficacy of single-dose versus seven-day trimethoprim treatment of cystitis in women: a randomized double-blind study. ( Aberg, H; Hallander, HO; Kallner, A; Lundin, A; Osterberg, E, 1990) |
| "A randomised single-blind clinical trial compared cinoxacin (500 mg every 12 hours) to co-trimoxazole (160 mg trimethoprim, 800 mg sulphamethoxazole every 12 hours) in the treatment of 63 patients with urinary tract infections." | 9.05 | Comparison of cinoxacin and co-trimoxazole in the treatment of urinary tract infections. ( de Jersey, P; Wooller, HO, 1982) |
| "Women with uncomplicated urinary tract infections were randomly allocated to either a single 150 mg intramuscular dose of netilmicin or a standard five-day course of oral co-trimoxazole." | 9.05 | Comparison of single dose netilmicin with a five-day course of co-trimoxazole for uncomplicated urinary tract infections. ( Bailey, RR; Blake, E; Peddie, BA, 1984) |
| "A multicenter, prospective, double-blind, controlled study was performed to compare the efficacy of trimethoprim-sulfamethoxazole with that of ampicillin in the treatment of chronic urinary tract infections." | 9.04 | Trimethoprim-sulfamethoxazole vs ampicillin in chronic urinary tract infections. A double-blind multicenter cooperative controlled study. ( Gleckman, RA, 1975) |
| "To assess whether trimethoprim remains an appropriate empiric treatment for uncomplicated cystitis in women 15-55 years old." | 7.96 | Appropriateness of trimethoprim as empiric treatment for cystitis in 15-55 year-old women: an audit. ( Elvy, JA; McAuliffe, GN; Upton, A; Ussher, JE, 2020) |
| "In recent years, high frequencies of trimethoprim resistance in urinary tract infections (UTIs) caused by E." | 7.91 | Use of other antimicrobial drugs is associated with trimethoprim resistance in patients with urinary tract infections caused by E. coli. ( Goessens, W; Lous, J; Mulder, M; Stricker, BH; Verbon, A, 2019) |
| "Trimethoprim has been recently included in the French guidelines for the treatment of urinary tract infections, but no epidemiological data supports its use." | 7.88 | Trimethoprim susceptibility in E. coli community-acquired urinary tract infections in France. ( Duployez, C; Robert, J; Vachée, A, 2018) |
| "The importance of high intrarenal levels of gentamicin on the outcome of experimental pyelonephritis was studied in rats receiving either a short course (three days) of gentamicin (G) alone or combined with a longer course (14 days) of ampicillin (A), cephalothin (C), or trimethoprim (T), or two weeks of therapy with ampicillin, cephalothin, trimethoprim and gentamicin given alone." | 7.67 | Benefit from high intrarenal levels of gentamicin in the treatment of E. coli pyelonephritis. ( Bergeron, MG; Marois, Y, 1986) |
| "This study examines the causes for the therapeutic failure of trimethoprim-sulfamethoxazole in a patient with infected cysts caused by a sensitive strain of Escherichia coli." | 7.67 | Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease. ( Schwab, SJ; Weaver, ME, 1986) |
| "-coli-022-pyelonephritis (PN) were treated twice daily for 9 days with 30 mg trimethoprim and 150 mg sulfamethoxazole (TMP-SMO) i." | 7.67 | [Kidney function and bacteriological and histological research in the therapy of experimental E. coli pyelonephritis using trimethoprim-sulfamethoxazole (TMP-SMO)]. ( Briedigkeit, H; Ditscherlein, G; Hagemann, I; Kruse, I; Neubrandt, C; Pietsch, R; Precht, K; Puls, U; Strangfeld, D, 1985) |
| "Efficacy of single-dose and 3-day trimethoprim-sulfadiazine (TMS) and amikacin treatment regimens for induced Escherichia coli urinary tract infections (UTI) in dogs was evaluated." | 7.67 | Effects of single-dose and three-day trimethoprim-sulfadiazine and amikacin treatment of induced Escherichia coli urinary tract infections in dogs. ( Lees, GE; Rogers, KS; Simpson, RB, 1988) |
| " At 50 mg/kg, both zidovudine and ampicillin reduced the number of bacteria in the kidneys of mice and prevented lethal infection in mice with ascending pyelonephritis caused by E." | 7.67 | In vivo efficacy of zidovudine (3'-azido-3'-deoxythymidine) in experimental gram-negative-bacterial infections. ( Keith, BR; White, G; Wilson, HR, 1989) |
| "A comparative study of the clinical, bacteriologic, and serum antibody titer response of 22 men who received therapy with trimethoprim-sulfamethoxazole for chronic prostatitis due to various strains of Escherichia coli was done." | 7.66 | Serum antibody titers in treatment with trimethoprim-sulfamethoxazole for chronic prostatitis. ( Meares, EM, 1978) |
| "Trimethoprim, in combination with sulfadiazine or sulfamethoxazole was administered orally for 7 to 14 days to 84 dogs with urinary tract infections (UTI)." | 7.66 | Trimethoprim in combination with a sulfonamide for oral treatment of canine urinary tract infections. ( Ling, GV; Ruby, AL, 1979) |
| "We used two strains of ampicillin-susceptible Escherichia coli to produce meningitis in rabbits and utilized these models (i) to compare the killing effects of parenteral trimethoprim-sulfamethoxazole (TMP-SMZ) and ampicillin on E." | 7.66 | Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits. ( Bates, TR; Beam, TR; Matson, RE; Mylotte, JM; Sergeant, KA, 1981) |
| "Co-trimazine, a new combination of trimethoprim and sulphadiazine intended for treatment of urinary tract infections, was tested and compared to co-trimoxazole in an experimental model of acute, obstructive pyelonephritis in the rat." | 7.66 | Efficacy of two trimethoprim-sulphonamide combinations in experimental pyelonephritis in the rat. ( Ritzerfeld, W, 1979) |
| "treatment with norfloxacin 200 mg or 400 mg or trimethoprim/sulfamethoxazole." | 6.66 | Norfloxacin versus co-trimoxazole for treatment of urinary tract infections in adults: microbiological results of a coordinated multicentre study. ( Norrby, SR; Rylander, M; Svärd, R, 1987) |
| " Among 33 patients given ofloxacin, the concentration of the drug in vaginal fluid during one dosage interval ranged from 1." | 6.66 | Pharmacodynamic evaluation of ofloxacin and trimethoprim-sulfamethoxazole in vaginal fluid of women treated for acute cystitis. ( Brust, P; Hooton, TM; Johnson, CR; Opheim, K; Stamm, WE; Tartaglione, TA, 1988) |
| "In a prospective randomized study 38 patients with recurrent urinary tract infections (rUTI) were included to take either 50 mg Nitrofurantoin (n = 19) or 50 mg Trimethoprim (n = 19) as low-dose long-term prophylaxis for half a year." | 5.07 | Nitrofurantoin versus trimethoprim for low-dose long-term prophylaxis in patients with recurrent urinary tract infections. A prospective randomized study. ( Vahlensieck, W; Westenfelder, M, 1992) |
| "A single dose of 100 mg ofloxacin was compared with a multiple dose of cotrimoxazole in lower urinary tract infections in 137 women." | 5.06 | Failure of a single dose of 100 mg ofloxacin in lower urinary tract infections in females. ( Forsgren, A; Ode, B; Walder, M, 1987) |
| "Two-hundred nine patients with symptoms of acute urinary tract infection and pyuria were randomized to 400 mg of administered norfloxacin twice daily for three days, or 800 mg of sulfamethoxazole and 160 mg of trimethoprim administered twice daily for ten days." | 5.06 | A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections. ( Boyko, EJ; Cox, CE; Goldstein, EJ; Kurtz, TO; Miller, K; Mummaw, N; Reller, LB; Stein, GE, 1987) |
| "Single-dose trimethoprim treatment of cystitis was compared with 7-day treatment in a randomized double-blind study in primary health care." | 5.06 | Efficacy of single-dose versus seven-day trimethoprim treatment of cystitis in women: a randomized double-blind study. ( Aberg, H; Hallander, HO; Kallner, A; Lundin, A; Osterberg, E, 1990) |
| "Acute lower urinary tract infections were treated in 57 women according to a randomized protocol, using either cefaclor, a cephalosporin whose chemical structure is similar to that of cephalexin, or trimethoprim-sulfamethoxazole combination." | 5.05 | A comparison of cefaclor versus trimethoprim-sulfamethoxazole combination in the treatment of acute urinary infections. ( Rous, SN, 1981) |
| "Women with uncomplicated urinary tract infections were randomly allocated to either a single 150 mg intramuscular dose of netilmicin or a standard five-day course of oral co-trimoxazole." | 5.05 | Comparison of single dose netilmicin with a five-day course of co-trimoxazole for uncomplicated urinary tract infections. ( Bailey, RR; Blake, E; Peddie, BA, 1984) |
| "A randomised single-blind clinical trial compared cinoxacin (500 mg every 12 hours) to co-trimoxazole (160 mg trimethoprim, 800 mg sulphamethoxazole every 12 hours) in the treatment of 63 patients with urinary tract infections." | 5.05 | Comparison of cinoxacin and co-trimoxazole in the treatment of urinary tract infections. ( de Jersey, P; Wooller, HO, 1982) |
| "Ninety patients with urinary tract infections were treated in a randomized double-blind study with either a combination of trimethoprim and sulfamethoxazole (TMP-SMX) or sulfamethoxazole alone (SMX)." | 5.04 | A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys. ( Boutros, P; Harding, GK; Lank, B; Ronald, AR, 1975) |
| "A multicenter, prospective, double-blind, controlled study was performed to compare the efficacy of trimethoprim-sulfamethoxazole with that of ampicillin in the treatment of chronic urinary tract infections." | 5.04 | Trimethoprim-sulfamethoxazole vs ampicillin in chronic urinary tract infections. A double-blind multicenter cooperative controlled study. ( Gleckman, RA, 1975) |
| "A prospective double-blind study was performed in which 30 adult patients with recurrent urinary tract infections due to Escherichia coli, and Proteus mirabilis organisms were treated by twenty-eight-day courses of either ampicillin, 500 mg." | 5.04 | Twenty-eight-day courses of antibiotics for urinary tract infection. ( Cosgrove, MD; Fiorentino, N; Gault, C; Ivler, D, 1976) |
| " Finally the combination of brodimoprim (BDP) and dapsone (DDS) was developed for the treatment of leprosy." | 4.78 | In vitro and in vivo results of brodimoprim and analogues alone and in combination against E. coli and mycobacteria. ( Seydel, JK, 1993) |
| "The antibiotic trimethoprim (TMP) is used to treat a variety of Escherichia coli infections, but its efficacy is limited by the rapid emergence of TMP-resistant bacteria." | 4.02 | A trimethoprim derivative impedes antibiotic resistance evolution. ( Ahmed, A; Atilgan, AR; Atilgan, C; Borek, D; Gaszek, I; Hulleman, JD; Koh, AY; Manna, MS; Poulides, N; Tambar, U; Tamer, YT; Toprak, E; Toprak, FCR; Wang, X; Williams, NS; Woodard, DR, 2021) |
| "To assess whether trimethoprim remains an appropriate empiric treatment for uncomplicated cystitis in women 15-55 years old." | 3.96 | Appropriateness of trimethoprim as empiric treatment for cystitis in 15-55 year-old women: an audit. ( Elvy, JA; McAuliffe, GN; Upton, A; Ussher, JE, 2020) |
| "In recent years, high frequencies of trimethoprim resistance in urinary tract infections (UTIs) caused by E." | 3.91 | Use of other antimicrobial drugs is associated with trimethoprim resistance in patients with urinary tract infections caused by E. coli. ( Goessens, W; Lous, J; Mulder, M; Stricker, BH; Verbon, A, 2019) |
| "Trimethoprim has been recently included in the French guidelines for the treatment of urinary tract infections, but no epidemiological data supports its use." | 3.88 | Trimethoprim susceptibility in E. coli community-acquired urinary tract infections in France. ( Duployez, C; Robert, J; Vachée, A, 2018) |
| " In this report, we present a trimethoprim conjugate of maltodextrin termed TM-TMP, which increased the water solubility of trimethoprim by over 100 times, was stable to serum enzymes, and was active against urinary tract infections in mice." | 3.88 | A Trimethoprim Conjugate of Thiomaltose Has Enhanced Antibacterial Efficacy In Vivo. ( Borges, CA; Lo Sterzo, C; Murthy, N; Ning, X; Park, B; Rafi, M; Riley, L; Takemiya, K; Taylor, WR; Wang, X; Zhang, J, 2018) |
| "The combination of trimethoprim/sulfamethoxazole is often used to treat uncomplicated urinary tract infections in children." | 3.76 | Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection. ( Defoor, WR; Elder, JS; Hurwitz, RS; McAdam, AJ; Minevich, E; Minnillo, BJ; Mortensen, JE; Nguyen, HT; Novak-Weekley, SM, 2010) |
| " coli isolates from cases of cystitis (Cys; n=239) or pyelonephritis (PN; n=89), with 169 from renal Tx recipients, were subjected to molecular analyses to identify P-fimbria subunits (PapC, PapG II, and PapGIII), G- and M-fimbriae, and aerobactin." | 3.76 | The role of host factors and bacterial virulence genes in the development of pyelonephritis caused by Escherichia coli in renal transplant recipients. ( Heilberg, IP; Medina-Pestana, JO; Rocha, LA; Siliano, PR, 2010) |
| "To assess changes in trimethoprim resistance over 2 years in bacteria causing uncomplicated urinary tract infections (UTIs) presenting to a representative group of general practitioners (GPs) in Christchurch." | 3.73 | Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern? ( Chambers, S; Harris, B; Ikram, R; Mangin, D; Toop, L, 2005) |
| " At 50 mg/kg, both zidovudine and ampicillin reduced the number of bacteria in the kidneys of mice and prevented lethal infection in mice with ascending pyelonephritis caused by E." | 3.67 | In vivo efficacy of zidovudine (3'-azido-3'-deoxythymidine) in experimental gram-negative-bacterial infections. ( Keith, BR; White, G; Wilson, HR, 1989) |
| "The effect of a single day treatment with 600 mg norfloxacin 600 mg ofloxacin or 1,920 mg trimethoprim-sulfamethoxazol was determined on 114 patients with acute cystitis." | 3.67 | [Single day treatment in acute cystitis]. ( Kawaguchi, K; Yamaguchi, K, 1988) |
| "The percentage of Shigella and enterotoxigenic Escherichia coli (ETEC) strains resistant to trimethoprim (TMP)-sulfamethoxazole isolated from children with diarrhea at the outpatient department of the Children's Hospital in Bangkok increased from 3 and 0%, respectively, in 1982 to 29% and 25% in 1986." | 3.67 | Trimethoprim-resistant Shigella and enterotoxigenic Escherichia coli strains in children in Thailand. ( Chatkaeomorakot, A; Echeverria, P; Leksomboon, U; Seriwatana, J; Taylor, DN, 1987) |
| "This study examines the causes for the therapeutic failure of trimethoprim-sulfamethoxazole in a patient with infected cysts caused by a sensitive strain of Escherichia coli." | 3.67 | Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease. ( Schwab, SJ; Weaver, ME, 1986) |
| "The importance of high intrarenal levels of gentamicin on the outcome of experimental pyelonephritis was studied in rats receiving either a short course (three days) of gentamicin (G) alone or combined with a longer course (14 days) of ampicillin (A), cephalothin (C), or trimethoprim (T), or two weeks of therapy with ampicillin, cephalothin, trimethoprim and gentamicin given alone." | 3.67 | Benefit from high intrarenal levels of gentamicin in the treatment of E. coli pyelonephritis. ( Bergeron, MG; Marois, Y, 1986) |
| "-coli-022-pyelonephritis (PN) were treated twice daily for 9 days with 30 mg trimethoprim and 150 mg sulfamethoxazole (TMP-SMO) i." | 3.67 | [Kidney function and bacteriological and histological research in the therapy of experimental E. coli pyelonephritis using trimethoprim-sulfamethoxazole (TMP-SMO)]. ( Briedigkeit, H; Ditscherlein, G; Hagemann, I; Kruse, I; Neubrandt, C; Pietsch, R; Precht, K; Puls, U; Strangfeld, D, 1985) |
| "Efficacy of single-dose and 3-day trimethoprim-sulfadiazine (TMS) and amikacin treatment regimens for induced Escherichia coli urinary tract infections (UTI) in dogs was evaluated." | 3.67 | Effects of single-dose and three-day trimethoprim-sulfadiazine and amikacin treatment of induced Escherichia coli urinary tract infections in dogs. ( Lees, GE; Rogers, KS; Simpson, RB, 1988) |
| "Co-trimazine, a new combination of trimethoprim and sulphadiazine intended for treatment of urinary tract infections, was tested and compared to co-trimoxazole in an experimental model of acute, obstructive pyelonephritis in the rat." | 3.66 | Efficacy of two trimethoprim-sulphonamide combinations in experimental pyelonephritis in the rat. ( Ritzerfeld, W, 1979) |
| "A comparative study of the clinical, bacteriologic, and serum antibody titer response of 22 men who received therapy with trimethoprim-sulfamethoxazole for chronic prostatitis due to various strains of Escherichia coli was done." | 3.66 | Serum antibody titers in treatment with trimethoprim-sulfamethoxazole for chronic prostatitis. ( Meares, EM, 1978) |
| "Trimethoprim, in combination with sulfadiazine or sulfamethoxazole was administered orally for 7 to 14 days to 84 dogs with urinary tract infections (UTI)." | 3.66 | Trimethoprim in combination with a sulfonamide for oral treatment of canine urinary tract infections. ( Ling, GV; Ruby, AL, 1979) |
| "We used two strains of ampicillin-susceptible Escherichia coli to produce meningitis in rabbits and utilized these models (i) to compare the killing effects of parenteral trimethoprim-sulfamethoxazole (TMP-SMZ) and ampicillin on E." | 3.66 | Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits. ( Bates, TR; Beam, TR; Matson, RE; Mylotte, JM; Sergeant, KA, 1981) |
| "Colonization of the vaginal introitus with Enterobacteriaceae was cleared dramatically in women receiving trimethoprim-sulfamethoxazole for recurrent urinary tract infections." | 3.65 | The diffusion and concentration of trimethoprim in human vaginal fluid. ( Condy, M; Stamey, TA, 1975) |
| "Trimethoprim resistance was more frequent amongst E." | 2.69 | A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. ( Bovill, B; Chattopadhyay, D; Duckworth, GJ; Lewis, DA; Minassian, MA; Williams, JD, 1998) |
| "Ofloxacin was well tolerated: adverse events were reported by 67 (12." | 2.67 | Ofloxacin versus trimethoprim and co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice. ( Cole, TP; Spencer, RC, 1992) |
| " Among 33 patients given ofloxacin, the concentration of the drug in vaginal fluid during one dosage interval ranged from 1." | 2.66 | Pharmacodynamic evaluation of ofloxacin and trimethoprim-sulfamethoxazole in vaginal fluid of women treated for acute cystitis. ( Brust, P; Hooton, TM; Johnson, CR; Opheim, K; Stamm, WE; Tartaglione, TA, 1988) |
| "treatment with norfloxacin 200 mg or 400 mg or trimethoprim/sulfamethoxazole." | 2.66 | Norfloxacin versus co-trimoxazole for treatment of urinary tract infections in adults: microbiological results of a coordinated multicentre study. ( Norrby, SR; Rylander, M; Svärd, R, 1987) |
| " Quinolones and the calcium salt of fosfomycin are useful but do not have an ideal pharmacokinetic profile." | 2.66 | The microbiological and pharmacokinetic profile of an antibacterial agent useful for the single-dose therapy of urinary tract infection. ( Greenwood, D; Slack, R, 1987) |
| "Treatment with trimethoprim reduced significantly the periurethral colonization of Escherichia coli." | 2.65 | Long-term prophylaxis of urinary infections in women: comparative trial of trimethoprim, methenamine hippurate and topical povidone-iodine. ( Brumfitt, W; Cooper, J; Gargan, RA; Hamilton-Miller, JM; Smith, GW, 1983) |
| "Urinary tract infections are one of the most common infections in primary and secondary care, with the majority of antimicrobial therapy initiated empirically before culture results are available." | 1.72 | E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community. ( Bakhshi, A; Barry, SJ; Leanord, A; Malcolm, W; McConnachie, A; McCowan, C; Santiago, VH, 2022) |
| " The aims of this study were to assess, in a PKPD framework, the empirical dosage regimen for a combination of trimethoprim (TMP) and sulfadiazine (SDZ) in mink, and secondarily to produce data for future setting of clinical breakpoints." | 1.62 | Validating an empiric sulfadiazine-trimethoprim dosage regimen for treatment of Escherichia coli and Staphylococcus delphini infections in mink (Neovison vison). ( Damborg, P; Frandsen, HL; Hansen, SG; Nikolaisen, NK; Poulsen, HH; Ronaghinia, AA; Struve, T; Toutain, PL, 2021) |
| "Trimethoprim prescription has implications for future resistance in individual children, as well as at population level." | 1.39 | Trimethoprim prescription and subsequent resistance in childhood urinary infection: multilevel modelling analysis. ( Davey, PG; Duffy, MA; Guthrie, B; Hernandez-Santiago, V; Orange, G, 2013) |
| "For ciprofloxacin the ORs were 2." | 1.38 | Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model. ( Bennett, K; Cormican, M; Hanahoe, B; Murphy, AW; Tansey, S; Vellinga, A, 2012) |
| "Ampicillin resistance was relatively stable over time, but varied between Health Regions." | 1.31 | Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antibacterial prescribing. ( George, RC; Gifford, T; James, D; Johnson, AP; Livermore, DM; Northcott, D; Speller, DC; Stephens, P; Weinberg, J, 2000) |
| "Trimethoprim resistance was found in 8, (8." | 1.31 | Antibiotic resistance in uncomplicated urinary tract infection: problems with interpreting cumulative resistance rates from local community laboratories. ( Chambers, ST; Harris, BH; Ikram, RB; Jones, MR; McGeoch, GR; Peddie, B; Richards, DA; Sutherland, MG; Toop, LJ, 2002) |
| " In contrast to TMP (half-life about one hour), BQP was well absorbed from the gastrointestinal tract in all ages of cattle, plasma concentrations reaching a plateau on the day after dosing followed by a slow decline." | 1.29 | Baquiloprim, a new antifolate antibacterial: in vitro activity and pharmacokinetic properties in cattle. ( Daluge, SM; Ferone, R; Sigel, CW; White, G; Wilson, HR, 1993) |
| "Body weight was the same in all groups." | 1.28 | Ascending pyelonephritis in young rats retards kidney growth. ( Aperia, A; Celsi, G; Eklöf, AC; Hannerz, L; Olling, S; Wikstad, I, 1989) |
| "Pharmacokinetic studies in broilers and layers of different sulphonamides indicate a good absorption and a long elimination half-life (of sulphaquinoxaline, sulphadimidine and to a lesser degree sulphadiazine) resulting in high plasma concentrations during drinking water medication in the recommended therapeutic doses." | 1.27 | Some pharmacokinetic aspects of four sulphonamides and trimethoprim, and their therapeutic efficacy in experimental Escherichia coli infection in poultry. ( de Jong, WA; Doornenbal, P; Goren, E, 1984) |
| "Trimethoprim resistance was carried on 12 different plasmids, four of which also conferred sulphonamide resistance." | 1.27 | Distribution and transferability of plasmids in trimethoprim resistant urinary Escherichia coli. ( Kraft, CA; Platt, DJ; Timbury, MC, 1983) |
| "Urinary malakoplakia may pursue an aggressive clinical course with persistent infection, despite seemingly appropriate antibiotic therapy." | 1.27 | Intracellular Escherichia coli in urinary malakoplakia: a reservoir of infection and its therapeutic implications. ( Gupta, PK; Mendelsohn, G; Qualman, SJ, 1984) |
| "Norfloxacin was substantially more effective than trimethoprim-sulphamethoxazole in reducing the number of colony forming units from kidney homogenates when the test animals were diabetic." | 1.27 | Norfloxacin versus trimethoprim-sulphamethoxazole: efficacy in a model of ascending urinary tract infection in normal and streptozotocin-induced diabetic mice. ( Abruzzo, GK; Fromtling, RA; Gadebusch, HH; Gilfillan, EC; Pelak, BA, 1985) |
| "A case is described of malakoplakia involving the urinary tract and retroperitoneum with recalcitrant infection due to Escherichia coli which was not responsive to seemingly appropriate antibiotics and surgery for drainage, but which subsequently responded to treatment with trimethoprim-sulfamethoxazole." | 1.26 | Treatment of malakoplakia with trimethoprim-sulfamethoxazole. ( Berlin, BB; Maderazo, EG; Morhardt, C, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 141 (63.51) | 18.7374 |
| 1990's | 15 (6.76) | 18.2507 |
| 2000's | 19 (8.56) | 29.6817 |
| 2010's | 37 (16.67) | 24.3611 |
| 2020's | 10 (4.50) | 2.80 |
| Authors | Studies |
|---|---|
| Harris, NV | 1 |
| Smith, C | 1 |
| Bowden, K | 1 |
| Mendonça, N | 1 |
| Leitão, J | 1 |
| Manageiro, V | 1 |
| Ferreira, E | 1 |
| Caniça, M | 1 |
| Cattoir, V | 1 |
| Poirel, L | 1 |
| Nordmann, P | 1 |
| Rashid, U | 1 |
| Ahmad, W | 1 |
| Hassan, SF | 1 |
| Qureshi, NA | 1 |
| Niaz, B | 1 |
| Muhammad, B | 1 |
| Imdad, S | 1 |
| Sajid, M | 1 |
| Kobauri, P | 1 |
| Galenkamp, NS | 1 |
| Schulte, AM | 1 |
| de Vries, J | 1 |
| Simeth, NA | 1 |
| Maglia, G | 1 |
| Thallmair, S | 1 |
| Kolarski, D | 1 |
| Szymanski, W | 1 |
| Feringa, BL | 1 |
| Rahuman, HBH | 1 |
| Dhandapani, R | 1 |
| Palanivel, V | 1 |
| Thangavelu, S | 1 |
| Paramasivam, R | 1 |
| Muthupandian, S | 1 |
| Su, WL | 1 |
| Bredèche, MF | 1 |
| Dion, S | 1 |
| Dauverd, J | 1 |
| Condamine, B | 1 |
| Gutierrez, A | 1 |
| Denamur, E | 1 |
| Matic, I | 1 |
| Ali, F | 1 |
| Gul, S | 1 |
| Sabir, MS | 1 |
| Shakeela, Q | 1 |
| Rasheed, A | 1 |
| Andleeb, F | 1 |
| Ullah, A | 1 |
| Sardar, S | 1 |
| Ahmed, S | 1 |
| McCowan, C | 1 |
| Bakhshi, A | 1 |
| McConnachie, A | 1 |
| Malcolm, W | 1 |
| Barry, SJ | 1 |
| Santiago, VH | 1 |
| Leanord, A | 1 |
| Revitt-Mills, SA | 1 |
| Wright, EK | 1 |
| Vereker, M | 1 |
| O'Flaherty, C | 1 |
| McPherson, F | 1 |
| Dawson, C | 1 |
| van Oijen, AM | 1 |
| Robinson, A | 1 |
| Muloi, D | 1 |
| Kiiru, J | 1 |
| Ward, MJ | 1 |
| Hassell, JM | 1 |
| Bettridge, JM | 1 |
| Robinson, TP | 1 |
| van Bunnik, BAD | 1 |
| Chase-Topping, M | 1 |
| Robertson, G | 1 |
| Pedersen, AB | 1 |
| Fèvre, EM | 1 |
| Woolhouse, MEJ | 1 |
| Kang'ethe, EK | 1 |
| Kariuki, S | 1 |
| Mulder, M | 1 |
| Verbon, A | 2 |
| Lous, J | 1 |
| Goessens, W | 1 |
| Stricker, BH | 1 |
| Mabboux, P | 1 |
| Rouveix, B | 1 |
| Ussher, JE | 1 |
| McAuliffe, GN | 1 |
| Elvy, JA | 1 |
| Upton, A | 1 |
| Ronaghinia, AA | 1 |
| Nikolaisen, NK | 1 |
| Hansen, SG | 1 |
| Poulsen, HH | 1 |
| Frandsen, HL | 1 |
| Struve, T | 1 |
| Toutain, PL | 1 |
| Damborg, P | 1 |
| Fatsis-Kavalopoulos, N | 1 |
| Roemhild, R | 1 |
| Tang, PC | 1 |
| Kreuger, J | 1 |
| Andersson, DI | 2 |
| Manna, MS | 1 |
| Tamer, YT | 1 |
| Gaszek, I | 1 |
| Poulides, N | 1 |
| Ahmed, A | 1 |
| Wang, X | 2 |
| Toprak, FCR | 1 |
| Woodard, DR | 1 |
| Koh, AY | 1 |
| Williams, NS | 1 |
| Borek, D | 1 |
| Atilgan, AR | 1 |
| Hulleman, JD | 1 |
| Atilgan, C | 1 |
| Tambar, U | 1 |
| Toprak, E | 1 |
| Wambaugh, MA | 1 |
| Shakya, VPS | 1 |
| Lewis, AJ | 1 |
| Mulvey, MA | 1 |
| Brown, JCS | 1 |
| Sellmyer, MA | 1 |
| Lee, I | 1 |
| Hou, C | 1 |
| Weng, CC | 1 |
| Li, S | 1 |
| Lieberman, BP | 1 |
| Zeng, C | 1 |
| Mankoff, DA | 1 |
| Mach, RH | 1 |
| Pouwels, KB | 1 |
| Batra, R | 1 |
| Patel, A | 1 |
| Edgeworth, JD | 1 |
| Robotham, JV | 1 |
| Smieszek, T | 1 |
| O'Halloran, C | 1 |
| Walsh, N | 1 |
| O'Grady, MC | 1 |
| Barry, L | 1 |
| Hooton, C | 1 |
| Corcoran, GD | 1 |
| Lucey, B | 1 |
| Kim, A | 1 |
| Lim, Y | 1 |
| Kim, N | 1 |
| Luan Nguyen, T | 1 |
| Roh, HJ | 1 |
| Park, CI | 1 |
| Han, HJ | 1 |
| Jung, SH | 1 |
| Cho, MY | 1 |
| Kim, DH | 1 |
| Smith, P | 1 |
| Borges, CA | 1 |
| Ning, X | 1 |
| Rafi, M | 1 |
| Zhang, J | 1 |
| Park, B | 1 |
| Takemiya, K | 1 |
| Lo Sterzo, C | 1 |
| Taylor, WR | 1 |
| Riley, L | 1 |
| Murthy, N | 1 |
| Duployez, C | 1 |
| Robert, J | 1 |
| Vachée, A | 1 |
| Lishman, H | 1 |
| Costelloe, C | 1 |
| Hopkins, S | 1 |
| Johnson, AP | 2 |
| Hope, R | 1 |
| Guy, R | 1 |
| Muller-Pebody, B | 1 |
| Holmes, A | 1 |
| Aylin, P | 1 |
| Podnecky, NL | 1 |
| Fredheim, EGA | 1 |
| Kloos, J | 1 |
| Sørum, V | 1 |
| Primicerio, R | 1 |
| Roberts, AP | 1 |
| Rozen, DE | 1 |
| Samuelsen, Ø | 1 |
| Johnsen, PJ | 1 |
| Duffy, MA | 1 |
| Hernandez-Santiago, V | 1 |
| Orange, G | 1 |
| Davey, PG | 1 |
| Guthrie, B | 1 |
| Kadlec, MW | 1 |
| You, D | 1 |
| Liao, JC | 1 |
| Wong, PK | 1 |
| Zhao, HX | 1 |
| Zhao, JL | 1 |
| Shen, JZ | 1 |
| Fan, HL | 1 |
| Guan, H | 1 |
| An, XP | 1 |
| Li, PF | 1 |
| Seo, MR | 1 |
| Kim, SJ | 1 |
| Kim, Y | 1 |
| Kim, J | 1 |
| Choi, TY | 1 |
| Kang, JO | 1 |
| Wie, SH | 1 |
| Ki, M | 1 |
| Cho, YK | 1 |
| Lim, SK | 1 |
| Lee, JS | 1 |
| Kwon, KT | 1 |
| Lee, H | 1 |
| Cheong, HJ | 1 |
| Park, DW | 1 |
| Ryu, SY | 1 |
| Chung, MH | 1 |
| Pai, H | 1 |
| Sundqvist, M | 2 |
| Granholm, S | 1 |
| Naseer, U | 1 |
| Rydén, P | 1 |
| Brolund, A | 1 |
| Sundsfjord, A | 1 |
| Kahlmeter, G | 3 |
| Johansson, A | 1 |
| Johns, IC | 1 |
| Adams, EL | 1 |
| Changkaew, K | 1 |
| Intarapuk, A | 1 |
| Utrarachkij, F | 1 |
| Nakajima, C | 1 |
| Suthienkul, O | 1 |
| Suzuki, Y | 1 |
| Gibbons, JF | 1 |
| Boland, F | 1 |
| Egan, J | 1 |
| Fanning, S | 1 |
| Markey, BK | 1 |
| Leonard, FC | 1 |
| Yahiaoui, M | 1 |
| Robin, F | 1 |
| Bakour, R | 1 |
| Hamidi, M | 1 |
| Bonnet, R | 1 |
| Messai, Y | 1 |
| Burke, L | 1 |
| Humphreys, H | 1 |
| Fitzgerald-Hughes, D | 1 |
| Chen, YT | 1 |
| Ahmad Murad, K | 1 |
| Ng, LS | 1 |
| Seah, JT | 1 |
| Park, JJ | 1 |
| Tan, TY | 1 |
| Fasugba, O | 1 |
| Mitchell, BG | 1 |
| Mnatzaganian, G | 1 |
| Das, A | 1 |
| Collignon, P | 1 |
| Gardner, A | 1 |
| Caron, F | 1 |
| Wehrle, V | 1 |
| Etienne, M | 1 |
| Taskinen, S | 1 |
| Giordano, S | 1 |
| Rintala, R | 1 |
| Bergman, M | 1 |
| Nyberg, ST | 1 |
| Huovinen, P | 2 |
| Paakkari, P | 1 |
| Hakanen, AJ | 1 |
| Ho, PL | 1 |
| Wong, RC | 1 |
| Chow, KH | 1 |
| Que, TL | 1 |
| Geli, P | 1 |
| Sjölund-Karlsson, M | 1 |
| Runehagen, A | 1 |
| Cars, H | 1 |
| Abelson-Storby, K | 1 |
| Cars, O | 1 |
| Šeputienė, V | 1 |
| Povilonis, J | 1 |
| Ružauskas, M | 1 |
| Pavilonis, A | 1 |
| Sužiedėlienė, E | 1 |
| Siliano, PR | 1 |
| Rocha, LA | 1 |
| Medina-Pestana, JO | 1 |
| Heilberg, IP | 1 |
| Nguyen, HT | 1 |
| Hurwitz, RS | 1 |
| Defoor, WR | 1 |
| Minevich, E | 1 |
| McAdam, AJ | 1 |
| Mortensen, JE | 1 |
| Novak-Weekley, SM | 1 |
| Minnillo, BJ | 1 |
| Elder, JS | 1 |
| Chakupurakal, R | 1 |
| Ahmed, M | 1 |
| Sobithadevi, DN | 1 |
| Chinnappan, S | 1 |
| Reynolds, T | 1 |
| Dheilly, A | 2 |
| Bouder, A | 2 |
| Le Devendec, L | 2 |
| Hellard, G | 1 |
| Kempf, I | 2 |
| Mourand, G | 1 |
| Jouy, E | 1 |
| Cullen, IM | 1 |
| Manecksha, RP | 1 |
| McCullagh, E | 1 |
| Ahmad, S | 2 |
| O'Kelly, F | 1 |
| Flynn, R | 1 |
| McDermott, TE | 1 |
| Murphy, P | 1 |
| Grainger, R | 1 |
| Fennell, JP | 1 |
| Thornhill, JA | 1 |
| Vellinga, A | 1 |
| Tansey, S | 1 |
| Hanahoe, B | 1 |
| Bennett, K | 1 |
| Murphy, AW | 1 |
| Cormican, M | 2 |
| Beerepoot, MA | 1 |
| ter Riet, G | 1 |
| Nys, S | 1 |
| van der Wal, WM | 1 |
| de Borgie, CA | 1 |
| de Reijke, TM | 1 |
| Prins, JM | 1 |
| Koeijers, J | 1 |
| Stobberingh, E | 1 |
| Geerlings, SE | 1 |
| Schmiemann, G | 1 |
| Gágyor, I | 1 |
| Hummers-Pradier, E | 1 |
| Bleidorn, J | 1 |
| Greko, C | 1 |
| Bengtsson, B | 1 |
| Franklin, A | 2 |
| Jacobsson, SO | 1 |
| Wiese, B | 1 |
| Luthman, J | 1 |
| Balagué, C | 1 |
| Fernández, L | 1 |
| Pérez, J | 1 |
| Grau, R | 1 |
| Uemura, R | 1 |
| Sueyoshi, M | 1 |
| Nagayoshi, M | 1 |
| Nagatomo, H | 1 |
| Yu, HS | 1 |
| Lee, JC | 1 |
| Kang, HY | 1 |
| Jeong, YS | 1 |
| Lee, EY | 1 |
| Choi, CH | 1 |
| Tae, SH | 1 |
| Lee, YC | 1 |
| Seol, SY | 1 |
| Cho, DT | 1 |
| Grape, M | 2 |
| Sundström, L | 1 |
| Kronvall, G | 2 |
| Larsson, M | 1 |
| Borén, C | 1 |
| Bartoloni, A | 1 |
| Rossolini, GM | 1 |
| Kristiansson, C | 1 |
| Karlsson, I | 1 |
| Mangin, D | 1 |
| Toop, L | 1 |
| Chambers, S | 1 |
| Ikram, R | 1 |
| Harris, B | 1 |
| Morris, D | 1 |
| Ni Chulain, M | 1 |
| Hillier, S | 1 |
| Roberts, Z | 1 |
| Dunstan, F | 1 |
| Butler, C | 1 |
| Howard, A | 1 |
| Palmer, S | 1 |
| Howe, RA | 1 |
| Qualman, SJ | 1 |
| Gupta, PK | 1 |
| Mendelsohn, G | 1 |
| Brumfitt, W | 5 |
| Hamilton-Miller, JM | 2 |
| Gargan, RA | 1 |
| Cooper, J | 2 |
| Smith, GW | 1 |
| Thorén, A | 1 |
| Wolde-Mariam, T | 1 |
| Stintzing, G | 1 |
| Wadström, T | 1 |
| Habte, D | 1 |
| Towner, KJ | 2 |
| DuPont, HL | 4 |
| Galindo, E | 3 |
| Evans, DG | 1 |
| Cabada, FJ | 1 |
| Sullivan, P | 1 |
| Evans, DJ | 1 |
| Merson, MH | 1 |
| Weiss, BD | 1 |
| Barriere, SL | 1 |
| Kapusnik, JE | 1 |
| Ericsson, CD | 2 |
| Dupont, MW | 1 |
| Mendiola Gomez, J | 1 |
| Kraft, CA | 2 |
| Platt, DJ | 2 |
| Timbury, MC | 2 |
| Kim, KS | 1 |
| Anthony, BF | 1 |
| Bailey, RR | 4 |
| Blake, E | 2 |
| Peddie, BA | 3 |
| Ottosson, J | 2 |
| Dawidson, I | 2 |
| Brandberg, A | 5 |
| Eriksson, B | 1 |
| Grüneberg, RN | 3 |
| Goren, E | 1 |
| de Jong, WA | 1 |
| Doornenbal, P | 1 |
| Wells, CL | 1 |
| Podzorski, RP | 1 |
| Peterson, PK | 1 |
| Ramsay, NK | 1 |
| Simmons, RL | 1 |
| Rhame, FS | 1 |
| Renneberg, J | 1 |
| Paerregaard, A | 1 |
| Sommerville, JS | 1 |
| Gossius, G | 1 |
| Vorland, L | 1 |
| Melby, K | 1 |
| Kolmannskog, S | 1 |
| Flaegstad, T | 1 |
| Wilk, S | 1 |
| Amtsberg, G | 1 |
| Meier, C | 1 |
| Ahlmén, J | 1 |
| Frisén, J | 1 |
| Ekbladh, G | 1 |
| Bilić, V | 1 |
| Zutić, M | 1 |
| Dujmić, A | 1 |
| Rukavina, V | 1 |
| Zurić, M | 1 |
| Ling, GV | 2 |
| Rawal, BD | 1 |
| Cottis, L | 1 |
| Rous, SN | 1 |
| Rebmann, U | 1 |
| Otto, HJ | 1 |
| Müller, GW | 1 |
| Freitag, J | 1 |
| Russ, GR | 1 |
| Mathew, TH | 1 |
| Caon, A | 1 |
| Chaudhary, S | 1 |
| Turner, RB | 1 |
| Mylotte, JM | 1 |
| Bates, TR | 1 |
| Sergeant, KA | 1 |
| Matson, RE | 1 |
| Beam, TR | 1 |
| Hussain, Z | 1 |
| Burchardt, P | 1 |
| Rosselet, A | 1 |
| Basler, W | 1 |
| Schluep, J | 1 |
| Heim, H | 1 |
| Kannangara, DW | 1 |
| Lefrock, JL | 1 |
| Black, RE | 1 |
| de Jersey, P | 1 |
| Wooller, HO | 1 |
| Reves, RR | 1 |
| Sullivan, PS | 1 |
| Wood, LV | 1 |
| Mendiola, JG | 1 |
| Seydel, JK | 1 |
| White, G | 2 |
| Daluge, SM | 1 |
| Sigel, CW | 1 |
| Ferone, R | 1 |
| Wilson, HR | 2 |
| Fang, W | 1 |
| Pyörälä, S | 1 |
| Tokunaga, T | 1 |
| Oka, K | 1 |
| Takemoto, A | 1 |
| Ohtsubo, Y | 1 |
| Gotoh, N | 1 |
| Nishino, T | 1 |
| Minassian, MA | 1 |
| Lewis, DA | 1 |
| Chattopadhyay, D | 1 |
| Bovill, B | 1 |
| Duckworth, GJ | 1 |
| Williams, JD | 1 |
| Livermore, DM | 1 |
| Stephens, P | 1 |
| Weinberg, J | 1 |
| Gifford, T | 1 |
| Northcott, D | 1 |
| James, D | 1 |
| George, RC | 1 |
| Speller, DC | 2 |
| Rivers, B | 1 |
| Steck, TR | 1 |
| Brown, PD | 1 |
| Freeman, A | 1 |
| Foxman, B | 1 |
| Richards, DA | 1 |
| Toop, LJ | 1 |
| Chambers, ST | 1 |
| Sutherland, MG | 1 |
| Harris, BH | 1 |
| Ikram, RB | 1 |
| Jones, MR | 1 |
| McGeoch, GR | 1 |
| Peddie, B | 1 |
| Baumueller, A | 1 |
| Madsen, PO | 2 |
| Marks, PJ | 1 |
| Bruten, DM | 2 |
| Pearson, NJ | 1 |
| Cattell, WR | 1 |
| O'Grady, F | 1 |
| Meares, EM | 4 |
| Demin, AA | 1 |
| Drobysheva, VP | 1 |
| Pepper, TA | 1 |
| Taylor, DJ | 1 |
| Mathews, DD | 1 |
| Ross, H | 1 |
| Wesolowski, S | 1 |
| Wencel, J | 1 |
| Czaplicki, M | 1 |
| Borkowski, A | 1 |
| Howard, JB | 1 |
| Howard, JE | 1 |
| Hirschl, A | 1 |
| Rotter, M | 1 |
| Ruby, AL | 1 |
| Maderazo, EG | 1 |
| Berlin, BB | 1 |
| Morhardt, C | 1 |
| Golikov, AV | 1 |
| Marchuk, AT | 1 |
| Vovk, AS | 1 |
| Shiriaeva, VT | 1 |
| Paisley, JW | 1 |
| Washington, JA | 1 |
| Ardati, KO | 1 |
| Thirumoorthi, MC | 1 |
| Dajani, AS | 1 |
| Ritzerfeld, W | 2 |
| Rilling, GJ | 1 |
| Lindblom, GB | 1 |
| Franzén, C | 1 |
| Romváry, A | 2 |
| Horvay, MS | 1 |
| Sabel, KG | 1 |
| Stamey, TA | 3 |
| Condy, M | 1 |
| Sher, N | 1 |
| Wong, CK | 1 |
| Harding, GK | 2 |
| Ronald, AR | 2 |
| Hoban, S | 1 |
| Boutros, P | 1 |
| Lank, B | 1 |
| Stansfeld, JM | 1 |
| Gleckman, RA | 3 |
| Verrier Jones, ER | 1 |
| Asscher, AW | 1 |
| Leakey, A | 1 |
| Bendall, MJ | 1 |
| Smellie, JM | 1 |
| Cosgrove, MD | 2 |
| Gault, C | 1 |
| Fiorentino, N | 1 |
| Ivler, D | 1 |
| Spencer, RC | 1 |
| Cole, TP | 1 |
| Gaudreault, P | 1 |
| Beland, M | 1 |
| Girodias, JB | 1 |
| Thivierge, RL | 1 |
| Jansson, C | 1 |
| Sköld, O | 1 |
| Bandres, JC | 1 |
| Mathewson, JJ | 1 |
| Vahlensieck, W | 1 |
| Westenfelder, M | 1 |
| Idvall, J | 1 |
| Sandor, Z | 1 |
| Aagaard, J | 1 |
| Gasser, T | 1 |
| Rhodes, P | 1 |
| Osterberg, E | 1 |
| Aberg, H | 1 |
| Hallander, HO | 1 |
| Kallner, A | 1 |
| Lundin, A | 1 |
| Webster, CJ | 1 |
| Obaseiki-Ebor, EE | 1 |
| Abiodun, PO | 1 |
| Emina, PA | 1 |
| Cox, CE | 2 |
| Drylie, DM | 1 |
| Klimberg, I | 1 |
| Childs, SJ | 1 |
| Wegenke, JD | 2 |
| Malek, GH | 2 |
| Harrison, LH | 1 |
| McCullough, DL | 1 |
| Finegold, SM | 1 |
| George, WL | 1 |
| Kennelly, MJ | 1 |
| Oesterling, JE | 1 |
| Weernink, EE | 1 |
| de Boer, MJ | 1 |
| Brutel de la Rivière, A | 1 |
| Keith, BR | 1 |
| Hannerz, L | 1 |
| Celsi, G | 1 |
| Eklöf, AC | 1 |
| Olling, S | 1 |
| Wikstad, I | 1 |
| Aperia, A | 1 |
| Adeyeba, OA | 1 |
| Renkonen, OV | 1 |
| Pulkkinen, L | 1 |
| Sunila, R | 1 |
| Grönroos, P | 1 |
| Klossner, ML | 1 |
| Virtanen, S | 1 |
| Toivanen, P | 1 |
| Yamaguchi, K | 1 |
| Kawaguchi, K | 1 |
| Tartaglione, TA | 1 |
| Johnson, CR | 1 |
| Brust, P | 1 |
| Opheim, K | 1 |
| Hooton, TM | 1 |
| Stamm, WE | 1 |
| Rogers, KS | 1 |
| Lees, GE | 1 |
| Simpson, RB | 1 |
| Muhvich, KH | 1 |
| Myers, RA | 1 |
| Marzella, L | 1 |
| Sacks-Berg, A | 1 |
| Strampfer, MJ | 1 |
| Cunha, BA | 1 |
| Stein, GE | 1 |
| Mummaw, N | 1 |
| Goldstein, EJ | 1 |
| Boyko, EJ | 1 |
| Reller, LB | 1 |
| Kurtz, TO | 1 |
| Miller, K | 1 |
| Chatkaeomorakot, A | 1 |
| Echeverria, P | 1 |
| Taylor, DN | 1 |
| Seriwatana, J | 1 |
| Leksomboon, U | 1 |
| Rylander, M | 1 |
| Norrby, SR | 1 |
| Svärd, R | 1 |
| Ode, B | 1 |
| Walder, M | 1 |
| Forsgren, A | 1 |
| Gorrie, SI | 1 |
| Davies, PR | 1 |
| Dubini, F | 1 |
| Riviera, L | 1 |
| Visconti, A | 1 |
| Alter, AJ | 1 |
| Olson, JG | 1 |
| Schwab, SJ | 1 |
| Weaver, ME | 1 |
| Rydberg, J | 1 |
| Cederberg, A | 1 |
| Bergeron, MG | 1 |
| Marois, Y | 1 |
| Slack, R | 1 |
| Greenwood, D | 1 |
| Räisänen, S | 1 |
| Ylitalo, P | 1 |
| Toponen, A | 1 |
| Seppänen, J | 1 |
| Ukhin, AV | 1 |
| Rosenberg, JM | 1 |
| Levy, RC | 1 |
| Cicmanec, JF | 1 |
| Hedges, JR | 1 |
| Burke, BM | 1 |
| Tanphaichitra, D | 1 |
| Schwöbel, M | 1 |
| Hirsig, J | 1 |
| Stauffer, UG | 1 |
| Verheijden, JH | 1 |
| van Miert, AS | 1 |
| Fromtling, RA | 1 |
| Abruzzo, GK | 1 |
| Gilfillan, EC | 1 |
| Pelak, BA | 1 |
| Gadebusch, HH | 1 |
| Hagemann, I | 1 |
| Briedigkeit, H | 1 |
| Strangfeld, D | 1 |
| Precht, K | 1 |
| Ditscherlein, G | 1 |
| Puls, U | 1 |
| Neubrandt, C | 1 |
| Pietsch, R | 1 |
| Kruse, I | 1 |
| Söyletir, G | 1 |
| Günalp, A | 1 |
| Reece, RL | 1 |
| Coloe, PJ | 1 |
| Lacey, RW | 1 |
| Gillespie, WA | 1 |
| Lewis, EL | 1 |
| Prát, V | 2 |
| Hatala, M | 1 |
| Konícková, L | 1 |
| Grunberg, E | 2 |
| Dungan, RW | 1 |
| Drach, GW | 1 |
| Lang, GR | 1 |
| Levin, S | 1 |
| Erwa, HH | 1 |
| Pursell, R | 1 |
| Schach, H | 1 |
| Scheidt, J | 1 |
| Neussel, H | 1 |
| Langlois, Y | 1 |
| Mélançon, J | 1 |
| Tétreault, L | 1 |
| Wilfert, CM | 1 |
| Forbes, PA | 1 |
| Drummond, KN | 1 |
| Shaw, EJ | 1 |
| Pursell, RE | 1 |
| Datta, N | 1 |
| Kirwan, WO | 1 |
| Morrow, JW | 1 |
| Lemieux, G | 1 |
| Tauchnitz, C | 2 |
| Ellorhaoui, M | 1 |
| Devriese, LA | 1 |
| Hommez, J | 1 |
| Bengtsson, E | 1 |
| Svanbom, M | 1 |
| Tunevall, G | 1 |
| Tanner, EI | 1 |
| Bullin, CH | 1 |
| Kovács, J | 1 |
| Magyar, K | 1 |
| Yamamoto, T | 1 |
| Hoffer, M | 1 |
| Mitrovic, M | 1 |
| Brossi, A | 1 |
| Porpáczy, P | 1 |
| Dargie, HJ | 1 |
| Allison, ME | 1 |
| McGeachie, J | 1 |
| Macdonald, GA | 1 |
| Kennedy, AC | 1 |
| Gavras, H | 1 |
| Lawson, DH | 1 |
| Linton, AL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing Due to New Episodes of Urinary Tract Infections (UTI) in Elderly Women With Recurrent UTI - a Triple- Blinded, Randomized Placebo-controlled Phase IV Study[NCT04077580] | Phase 4 | 400 participants (Anticipated) | Interventional | 2019-11-01 | Enrolling by invitation | ||
| BeaRberry in the Treatment of Acute UncoMplIcated Cystitis (BRUMI)- Protocol of a Multicentre, Randomized Double-Blind Clinical Trial[NCT05055544] | 504 participants (Anticipated) | Interventional | 2021-10-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for trimethoprim and E coli Infections
| Article | Year |
|---|---|
The comeback of trimethoprim in France.
Topics: Anti-Bacterial Agents; Cystitis; Drug Resistance, Bacterial; Drug Utilization; Escherichia coli; Esc | 2017 |
Trimethoprim.
Topics: Anti-Infective Agents, Urinary; Bacteriuria; Drug Resistance, Microbial; Drug Therapy, Combination; | 1980 |
Treatment of urinary tract infections.
Topics: Ampicillin; Animals; Dog Diseases; Dogs; Escherichia coli Infections; Penicillin G; Penicillin Resis | 1980 |
The prophylaxis and therapy of secretory diarrhea.
Topics: Anti-Infective Agents, Urinary; Antidiarrheals; Chloramphenicol; Chlorpromazine; Cholera; Diarrhea; | 1982 |
In vitro and in vivo results of brodimoprim and analogues alone and in combination against E. coli and mycobacteria.
Topics: Dapsone; Dihydropteroate Synthase; Escherichia coli; Escherichia coli Infections; Humans; Leprosy; M | 1993 |
Conservative management of a seminal vesicle abscess.
Topics: Abscess; Anti-Infective Agents; Drug Combinations; Escherichia coli Infections; Genital Diseases, Ma | 1989 |
Escherichia coli sacroiliitis: report of a case and review of the literature.
Topics: Adolescent; Arthritis, Infectious; Cefazolin; Drug Combinations; Escherichia coli Infections; Galliu | 1988 |
[Present status of the treatment of urological infections].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Cross Infection; Dru | 1985 |
The effect of trimethoprim on the activity of sulfonamides and antibiotics in experimental infections.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacterial Infections; Drug Synergism; Escheric | 1973 |
Diagnosis and treatment of urinary tract infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteriuria; Cephalosporins; Chloramphenicol; | 1971 |
Lettsomian lectures. Mondays, February 11th and 25th, 1974. Urinary infection.
Topics: Antigens, Bacterial; Bacteriological Techniques; Bacteriuria; Coitus; Escherichia coli; Escherichia | 1974 |
[Results of chemotherapy of intestinal infections].
Topics: Anti-Bacterial Agents; Bacterial Infections; Diarrhea; Drug Resistance, Microbial; Dysentery, Bacill | 1972 |
39 trials available for trimethoprim and E coli Infections
| Article | Year |
|---|---|
Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Double-Blind Method; Drug Combinations; Drug Resistance, B | 2012 |
Long-term prophylaxis of urinary infections in women: comparative trial of trimethoprim, methenamine hippurate and topical povidone-iodine.
Topics: Administration, Topical; Adult; Clinical Trials as Topic; Drug Eruptions; Drug Resistance, Microbial | 1983 |
Antibiotics in the treatment of gastroenteritis caused by enteropathogenic Escherichia coli.
Topics: Amdinocillin; Clinical Trials as Topic; Escherichia coli; Escherichia coli Infections; Female; Gastr | 1980 |
Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole and trimethoprim alone.
Topics: Adult; Diarrhea; Drug Combinations; Dysentery, Bacillary; Escherichia coli Infections; Female; Human | 1983 |
Prevention of traveler's diarrhea.
Topics: Diarrhea; Doxycycline; Drug Combinations; Erythromycin; Escherichia coli Infections; Humans; Premedi | 1983 |
Antimicrobial therapy of travellers' diarrhoea.
Topics: Anti-Infective Agents; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Clinical | 1983 |
Comparison of single dose netilmicin with a five-day course of co-trimoxazole for uncomplicated urinary tract infections.
Topics: Administration, Oral; Adolescent; Adult; Clinical Trials as Topic; Drug Combinations; Escherichia co | 1984 |
Single-day treatment with trimethoprim for asymptomatic bacteriuria in the elderly patient.
Topics: Aged; Bacteriuria; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Esch | 1984 |
A randomised comparison of single-dose vs. three-day and ten-day therapy with trimethoprim-sulfamethoxazole for acute cystitis in women.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents, Urinary; Cystitis; Drug Administration Sche | 1984 |
Treatment of uncomplicated urinary tract infections with a single dose of co-trimoxazole.
Topics: Adolescent; Adult; Bacterial Infections; Drug Combinations; Escherichia coli Infections; Female; Hum | 1980 |
A comparison of cefaclor versus trimethoprim-sulfamethoxazole combination in the treatment of acute urinary infections.
Topics: Adolescent; Adult; Anti-Infective Agents, Urinary; Cefaclor; Cephalexin; Clinical Trials as Topic; D | 1981 |
Single day or single dose treatment of urinary tract infection with Co-trimoxazole.
Topics: Drug Administration Schedule; Drug Combinations; Escherichia coli Infections; Female; Humans; Sulfam | 1980 |
Comparison of cinoxacin and co-trimoxazole in the treatment of urinary tract infections.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Bacteriuria; Cinoxacin; Clinical Trials as | 1982 |
Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone.
Topics: Adult; Clinical Trials as Topic; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Dysentery | 1982 |
A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Citrobacter; Drug Administration | 1998 |
A double-blind trial of single-dose chemoprophylaxis with co-trimoxazole during total abdominal hysterectomy.
Topics: Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Escherichia coli Infections; Femal | 1977 |
Trimethoprim-sulfamethoxazole vs sulfamethoxazole for acute urinary tract infections in children.
Topics: Acute Disease; Bacterial Infections; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind | 1978 |
Co-trimoxazole in cases of gram-negative septicaemia.
Topics: Adolescent; Adult; Aged; Bacteroides Infections; Clinical Trials as Topic; Drug Combinations; Drug E | 1976 |
A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys.
Topics: Administration, Oral; Adolescent; Adult; Aged; Bacterial Infections; Clinical Trials as Topic; Drug | 1975 |
Duration of treatment for urinary tract infections in children.
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Escherichia coli I | 1975 |
Trimethoprim-sulfamethoxazole vs ampicillin in chronic urinary tract infections. A double-blind multicenter cooperative controlled study.
Topics: Adult; Ampicillin; Chronic Disease; Clinical Trials as Topic; Drug Synergism; Escherichia coli Infec | 1975 |
Treatment of recurrent bacteriuria with pivmecillinam (FL 1039).
Topics: Ampicillin; Azepines; Bacteriuria; Child; Clinical Trials as Topic; Drug Combinations; Escherichia c | 1975 |
Twenty-eight-day courses of antibiotics for urinary tract infection.
Topics: Adult; Aged; Ampicillin; Drug Administration Schedule; Drug Therapy, Combination; Escherichia coli I | 1976 |
Ofloxacin versus trimethoprim and co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice.
Topics: Adult; Aged; Escherichia coli Infections; Family Practice; Female; Humans; Male; Middle Aged; Ofloxa | 1992 |
Single daily doses of trimethoprim/sulphadiazine for three or 10 days in urinary tract infections.
Topics: Adolescent; Anti-Infective Agents, Urinary; Child; Child, Preschool; Drug Combinations; Escherichia | 1992 |
Nitrofurantoin versus trimethoprim for low-dose long-term prophylaxis in patients with recurrent urinary tract infections. A prospective randomized study.
Topics: Adult; Escherichia coli Infections; Female; Humans; Male; Nitrofurantoin; Patient Compliance; Prospe | 1992 |
Efficacy of single-dose versus seven-day trimethoprim treatment of cystitis in women: a randomized double-blind study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cystitis; Double-Blind Method; Drug Administration Sched | 1990 |
A multicenter, double-blind, trimethoprim-sulfamethoxazole controlled study of enoxacin in the treatment of patients with complicated urinary tract infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Double-Blind Method; Drug Combinatio | 1989 |
Pharmacodynamic evaluation of ofloxacin and trimethoprim-sulfamethoxazole in vaginal fluid of women treated for acute cystitis.
Topics: Administration, Oral; Adult; Body Fluids; Cystitis; Drug Administration Schedule; Drug Combinations; | 1988 |
A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Drug Administra | 1987 |
Norfloxacin versus co-trimoxazole for treatment of urinary tract infections in adults: microbiological results of a coordinated multicentre study.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Escherichia | 1987 |
Failure of a single dose of 100 mg ofloxacin in lower urinary tract infections in females.
Topics: Anti-Infective Agents, Urinary; Clinical Trials as Topic; Drug Combinations; Escherichia coli Infect | 1987 |
Double blind, randomised trial comparing single dose enoxacin and trimethoprim for treatment of bacterial cystitis.
Topics: Adolescent; Adult; Anti-Infective Agents, Urinary; Clinical Trials as Topic; Cystitis; Double-Blind | 1987 |
The microbiological and pharmacokinetic profile of an antibacterial agent useful for the single-dose therapy of urinary tract infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Clinical Trials as Topic; Dr | 1987 |
Single-dose ceftriaxone treatment of urinary tract infections.
Topics: Administration, Oral; Cefotaxime; Ceftriaxone; Drug Combinations; Drug Evaluation; Escherichia coli | 1985 |
Double-blind trial to compare ampicillin, cephalexin, co-trimoxazole, and trimethoprim in treatment of urinary infection.
Topics: Ampicillin; Bacteriuria; Cephalexin; Cephalosporins; Drug Hypersensitivity; Escherichia coli Infecti | 1972 |
[Results of treatment with trimethoprim-sulfamethoxazole in nonspecific urinary tract infections in pediatric urology].
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Chronic Disease; Clinical Trials as Topi | 1972 |
[Combination of trimethoprim and sulfamethoxazole in coliform urinary infections].
Topics: Analysis of Variance; Anti-Infective Agents, Urinary; Clinical Trials as Topic; Drug Combinations; D | 1973 |
A cooperative controlled study of the use of trimethoprim-sulfamethoxazole in chronic urinary tract infections.
Topics: Chronic Disease; Clinical Trials as Topic; Drug Combinations; Enterobacteriaceae Infections; Escheri | 1973 |
171 other studies available for trimethoprim and E coli Infections
| Article | Year |
|---|---|
Antifolate and antibacterial activities of 5-substituted 2,4-diaminoquinazolines.
Topics: Animals; Anti-Bacterial Agents; Cattle; Chemical Phenomena; Chemistry; Escherichia coli; Escherichia | 1990 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug R | 2007 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Esch | 2008 |
Design, synthesis, antibacterial activity and docking study of some new trimethoprim derivatives.
Topics: Anti-Bacterial Agents; Drug Design; Escherichia coli; Escherichia coli Infections; Humans; Microbial | 2016 |
Hypothesis-Driven, Structure-Based Design in Photopharmacology: The Case of eDHFR Inhibitors.
Topics: Drug Design; Escherichia coli; Escherichia coli Infections; Humans; Isomerism; Tetrahydrofolate Dehy | 2022 |
Bioengineered phytomolecules-capped silver nanoparticles using Carissa carandas leaf extract to embed on to urinary catheter to combat UTI pathogens.
Topics: Anti-Bacterial Agents; Apocynaceae; Biofilms; Ciprofloxacin; Escherichia coli; Escherichia coli Infe | 2021 |
TisB Protein Protects Escherichia coli Cells Suffering Massive DNA Damage from Environmental Toxic Compounds.
Topics: Animals; Anti-Bacterial Agents; Colicins; DNA Damage; Escherichia coli; Escherichia coli Infections; | 2022 |
Comparative in vitro activity of selected antibacterial agents against Escherichia coli isolated from hospitalized patients suffering UTI.
Topics: Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Sulfamethoxa | 2022 |
E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bacteremia; Drug Res | 2022 |
Defects in DNA double-strand break repair resensitize antibiotic-resistant Escherichia coli to multiple bactericidal antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Repair; DNA, Bacterial; Escherichia coli; Escherichia coli | 2022 |
Epidemiology of antimicrobial-resistant Escherichia coli carriage in sympatric humans and livestock in a rapidly urbanizing city.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cross-Sectional Studies; Drug Resistance, Multiple, | 2019 |
Use of other antimicrobial drugs is associated with trimethoprim resistance in patients with urinary tract infections caused by E. coli.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Drug Resistance, Multiple, Bac | 2019 |
[Current state of resistance of E. coli to trimethoprim in uncomplicated urinary tract infections in France].
Topics: Acute Disease; Adolescent; Adult; Cystitis; Escherichia coli; Escherichia coli Infections; Female; F | 2019 |
Appropriateness of trimethoprim as empiric treatment for cystitis in 15-55 year-old women: an audit.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cystitis; Drug Resistance, Bacterial; Escherichia coli; Es | 2020 |
Validating an empiric sulfadiazine-trimethoprim dosage regimen for treatment of Escherichia coli and Staphylococcus delphini infections in mink (Neovison vison).
Topics: Animals; Anti-Infective Agents, Urinary; Area Under Curve; Drug Combinations; Escherichia coli; Esch | 2021 |
CombiANT: Antibiotic interaction testing made easy.
Topics: Algorithms; Amdinocillin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Synergis | 2020 |
A trimethoprim derivative impedes antibiotic resistance evolution.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Crystallography, X-Ray; Directed Molecular Evolution | 2021 |
High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacterial Proteins; Biological Assay | 2017 |
Bacterial infection imaging with [
Topics: Animals; Anti-Bacterial Agents; Cell Line; Disease Models, Animal; Escherichia coli; Escherichia col | 2017 |
Will co-trimoxazole resistance rates ever go down? Resistance rates remain high despite decades of reduced co-trimoxazole consumption.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; England; Escherichia coli; Escherichia coli Infec | 2017 |
Assessment of the comparability of CLSI, EUCAST and Stokes antimicrobial susceptibility profiles for Escherichia coli uropathogenic isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cepha | 2018 |
A Comparison of Genotypic and Phenotypic Methods for Analyzing the Susceptibility to Sulfamethoxazole and Trimethoprim in Edwardsiella piscicida.
Topics: Animals; Anti-Bacterial Agents; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Edwa | 2018 |
A Trimethoprim Conjugate of Thiomaltose Has Enhanced Antibacterial Efficacy In Vivo.
Topics: Animals; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Female; Maltose; Mice | 2018 |
Trimethoprim susceptibility in E. coli community-acquired urinary tract infections in France.
Topics: Adolescent; Adult; Anti-Infective Agents, Urinary; Community-Acquired Infections; Escherichia coli; | 2018 |
Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antimicrobial resistance: an ecological study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Bacterial; Engla | 2018 |
Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli.
Topics: Amdinocillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Es | 2018 |
Trimethoprim prescription and subsequent resistance in childhood urinary infection: multilevel modelling analysis.
Topics: Adolescent; Age of Onset; Anti-Infective Agents, Urinary; Child; Child, Preschool; Escherichia coli; | 2013 |
A Cell Phone-Based Microphotometric System for Rapid Antimicrobial Susceptibility Testing.
Topics: Ampicillin; Anti-Bacterial Agents; Automation, Laboratory; Cell Phone; Chromogenic Compounds; Ciprof | 2014 |
Prevalence and molecular characterization of fluoroquinolone resistance in Escherichia coli isolates from dairy cattle with endometritis in China.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; Cattle; Cattle Diseases; China; Ci | 2014 |
Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea.
Topics: Anti-Bacterial Agents; Cefepime; Cell Survival; Cephalosporins; Ciprofloxacin; Community-Acquired In | 2014 |
Within-population distribution of trimethoprim resistance in Escherichia coli before and after a community-wide intervention on trimethoprim use.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriuria; Child; Chromosome Ma | 2014 |
Trends in antimicrobial resistance in equine bacterial isolates: 1999-2012.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Enrof | 2015 |
Antimicrobial Resistance, Extended-Spectrum β-Lactamase Productivity, and Class 1 Integrons in Escherichia coli from Healthy Swine.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cross-Secti | 2015 |
Antimicrobial Resistance of Faecal Escherichia coli Isolates from Pig Farms with Different Durations of In-feed Antimicrobial Use.
Topics: Animal Feed; Animal Husbandry; Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Escherich | 2016 |
Antibiotic Resistance, Virulence, and Genetic Background of Community-Acquired Uropathogenic Escherichia coli from Algeria.
Topics: Adult; Aged; Algeria; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Community-Acquired Infec | 2015 |
The Molecular Epidemiology of Resistance in Cefotaximase-Producing Escherichia coli Clinical Isolates from Dublin, Ireland.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; DNA Transposable Elements; Drug Resistance, | 2016 |
In Vitro Efficacy of Six Alternative Antibiotics against Multidrug Resistant Escherichia Coli and Klebsiella Pneumoniae from Urinary Tract Infections.
Topics: Amdinocillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefpodoxime; Ceftibuten; C | 2016 |
Five-Year Antimicrobial Resistance Patterns of Urinary Escherichia coli at an Australian Tertiary Hospital: Time Series Analyses of Prevalence Data.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Australia; beta-Lactamases; Cross-Sectional Studies; Drug R | 2016 |
Xanthogranulomatous pyelonephritis infiltrating the liver.
Topics: Anti-Bacterial Agents; Cefuroxime; Cephalexin; Child; Clindamycin; Combined Modality Therapy; Divert | 2008 |
Association between antimicrobial consumption and resistance in Escherichia coli.
Topics: Ambulatory Care Facilities; Amdinocillin Pivoxil; Amoxicillin-Potassium Clavulanate Combination; Amp | 2009 |
Distribution of integron-associated trimethoprim-sulfamethoxazole resistance determinants among Escherichia coli from humans and food-producing animals.
Topics: Adult; Animals; Anti-Bacterial Agents; Cattle; Drug Resistance, Multiple, Bacterial; Escherichia col | 2009 |
Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use.
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; Drug Utilization; Escherichia coli; Esche | 2010 |
Prevalence of trimethoprim resistance genes in Escherichia coli isolates of human and animal origin in Lithuania.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Escherichia coli; Escherichia coli Infectio | 2010 |
The role of host factors and bacterial virulence genes in the development of pyelonephritis caused by Escherichia coli in renal transplant recipients.
Topics: Adhesins, Escherichia coli; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; | 2010 |
Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection.
Topics: Ampicillin; Analysis of Variance; Anti-Infective Agents, Urinary; Chi-Square Distribution; Child; Ch | 2010 |
Urinary tract pathogens and resistance pattern.
Topics: Adolescent; Age Distribution; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; | 2010 |
Clinical and microbial efficacy of antimicrobial treatments of experimental avian colibacillosis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Chickens; Drug Resistance, Bacterial; Enrofloxacin; Esc | 2011 |
Resistance gene transfer during treatments for experimental avian colibacillosis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; Bird Diseases; Chickens; D | 2012 |
An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; | 2013 |
Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Ciprofloxacin; Drug Prescriptions; Drug Re | 2012 |
Resistance profiles of urinary tract infections in general practice--an observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, B | 2012 |
Efficacy of trimethoprim-sulfadoxine against Escherichia coli in a tissue cage model in calves.
Topics: Animals; Area Under Curve; Cattle; Chromatography, High Pressure Liquid; Drug Combinations; Escheric | 2002 |
Effect of ciprofloxacin on adhesive properties of non-P mannose-resistant uropathogenic Escherichia coli isolates.
Topics: Adhesins, Bacterial; Anti-Infective Agents; Anti-Infective Agents, Urinary; Catheterization; Chemica | 2003 |
Antimicrobial susceptibilities of Shiga toxin-producing Escherichia coli isolates from pigs with edema disease in Japan.
Topics: 4-Quinolones; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bridged Bicyclo Compounds, Hete | 2003 |
Prevalence of dfr genes associated with integrons and dissemination of dfrA17 among urinary isolates of Escherichia coli in Korea.
Topics: Anti-Infective Agents, Urinary; Blotting, Southern; DNA-Binding Proteins; DNA, Bacterial; Drug Resis | 2004 |
New dfr2 gene as a single-gene cassette in a class 1 integron from a trimethoprim-resistant Escherichia coli isolate.
Topics: Amino Acid Sequence; Anti-Infective Agents, Urinary; DNA, Bacterial; Drug Resistance, Bacterial; Esc | 2003 |
Extended antimicrobial resistance screening of the dominant faecal Escherichia coli and of rare resistant clones.
Topics: Ampicillin; Anti-Bacterial Agents; Carrier State; Chloramphenicol; Drug Resistance, Bacterial; Esche | 2005 |
Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?
Topics: Adolescent; Adult; Age Distribution; Anti-Infective Agents, Urinary; Escherichia coli; Escherichia c | 2005 |
Dissemination of clonal groups of uropathogenic Escherichia coli is not a significant contributor to trimethoprim and sulfamethoxazole resistance in Galway, Ireland.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Hu | 2007 |
Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Case-Control Studies; Community-Acquired Infe | 2007 |
Over the counter medicines: Don't include trimethoprim.
Topics: Anti-Infective Agents, Urinary; Escherichia coli Infections; Humans; Nonprescription Drugs; Trimetho | 2008 |
Intracellular Escherichia coli in urinary malakoplakia: a reservoir of infection and its therapeutic implications.
Topics: Adult; Aged; Bacteriological Techniques; Bacteriuria; Bethanechol; Bethanechol Compounds; Drug Combi | 1984 |
A clinical isolate of Escherichia coli owing its trimethoprim resistance to a chromosomally-located trimethoprim transposon.
Topics: Conjugation, Genetic; Culture Media; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Mic | 1981 |
Traveler's diarrhea: update 1983.
Topics: Bismuth; Child; Diarrhea; Doxycycline; Drug Combinations; Escherichia coli Infections; Humans; Organ | 1983 |
Prevention and treatment of "traveler's diarrhea".
Topics: Bismuth; Diarrhea; Doxycycline; Drug Combinations; Escherichia coli Infections; Humans; Organometall | 1983 |
Distribution and transferability of plasmids in trimethoprim resistant urinary Escherichia coli.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Microbial; Escherichia | 1983 |
Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
Topics: Animals; Colony-Forming Units Assay; Drug Combinations; Escherichia coli Infections; Meningitis; Rat | 1983 |
Experimental septic shock: relative effects of treatment with antibiotics, crystalloid or colloid solution infusions and corticosteroids.
Topics: Animals; Colloids; Combined Modality Therapy; Dexamethasone; Drug Combinations; Escherichia coli Inf | 1984 |
Antibiotic sensitivities of urinary pathogens, 1971-82.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Cephaloridine; Drug Combinations; Escherichia coli I | 1984 |
Some pharmacokinetic aspects of four sulphonamides and trimethoprim, and their therapeutic efficacy in experimental Escherichia coli infection in poultry.
Topics: Animals; Chickens; Drug Combinations; Escherichia coli Infections; Kinetics; Poultry Diseases; Sulfa | 1984 |
Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients.
Topics: Bone Marrow Transplantation; Citrobacter; Drug Combinations; Drug Resistance, Microbial; Enterobacte | 1984 |
Severe thrombocytopenia-hemorrhage due to trimethoprim-sulfamethoxazole: a case report.
Topics: Aged; Anti-Infective Agents, Urinary; Drug Combinations; Escherichia coli Infections; Female; Hematu | 1984 |
Antimicrobial resistance and the ecology of Escherichia coli plasmids.
Topics: Ampicillin; Chloramphenicol; Escherichia coli; Escherichia coli Infections; Humans; Kanamycin; Penic | 1984 |
[Failure of peroral trimethoprim/sulfamethoxazole as infection preventive agent in acute lymphatic leukemia].
Topics: Child, Preschool; Drug Combinations; Drug Resistance, Microbial; Escherichia coli Infections; Humans | 1984 |
[Serotyping and drug resistance of Escherichia coli strains in healthy dogs and dogs with enteritis].
Topics: Animals; Dogs; Drug Resistance, Microbial; Enteritis; Escherichia coli; Escherichia coli Infections; | 1982 |
Experience of three-day trimethoprim therapy for dysuria-frequency in primary health care.
Topics: Adolescent; Adult; Drug Administration Schedule; Escherichia coli Infections; Female; Humans; Male; | 1982 |
[Systematic use of trimetosul in piglets with reference to possible E. coli resistance].
Topics: Animals; Diarrhea; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Escherichia coli | 1980 |
Evaluation of in vitro sensitivity testing methods of detecting sulphamethoxazole trimethoprim synergy. Correlation with mouse protection assay.
Topics: Animals; Bacteria; Drug Synergism; Escherichia coli Infections; Mice; Microbial Sensitivity Tests; S | 1980 |
[Radionuclide and radiographic studies for the evaluation of results of short and long-term therapy in experimental dog pyelonephritis].
Topics: Angiography; Animals; Dogs; Drug Administration Schedule; Drug Combinations; Escherichia coli Infect | 1980 |
Trimethoprim-sulfamethoxazole for cholangitis following hepatic portoenterostomy for biliary atresia.
Topics: Bacterial Infections; Bile Ducts; Cholangitis; Drug Combinations; Escherichia coli Infections; Femal | 1981 |
Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits.
Topics: Ampicillin; Animals; Brain; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections | 1981 |
[Therapy of noncomplicated urinary tract infections in women].
Topics: Ampicillin; Escherichia coli Infections; Female; Humans; Nalidixic Acid; Nitrofurantoin; Pipemidic A | 1981 |
Chemotherapeutic activity of the combination of sulfachloropyridazine and trimethoprim against experimental colibacillosis of chickens and piglets and demonstration of the trimethoprim-induced potentiation of sulfachloropyridazine in vitro and in vivo.
Topics: Animals; Chickens; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Poultry D | 1981 |
Drugs for urinary tract infections in women.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Escherichia coli Infections; Fem | 1981 |
Baquiloprim, a new antifolate antibacterial: in vitro activity and pharmacokinetic properties in cattle.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacillus; Biological Availability; Cattle; Esc | 1993 |
Mastitis-causing Escherichia coli: serum sensitivity and susceptibility to selected antibacterials in milk.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Blood Bactericidal Activity; Catt | 1996 |
Efficacy of trimethoprim in murine experimental infection with a thymidine kinase-deficient mutant of Escherichia coli.
Topics: Animals; Escherichia coli; Escherichia coli Infections; Male; Mice; Microbial Sensitivity Tests; Mut | 1997 |
Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antibacterial prescribing.
Topics: Ampicillin; Ampicillin Resistance; Anti-Infective Agents, Urinary; Bacteremia; Drug Prescriptions; D | 2000 |
Viable but nonculturable uropathogenic bacteria are present in the mouse urinary tract following urinary tract infection and antibiotic therapy.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; DNA, Bacterial; Escherichia coli; Es | 2001 |
Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Cohort Studies; Drug Combinations; Drug Res | 2002 |
Antibiotic resistance in uncomplicated urinary tract infection: problems with interpreting cumulative resistance rates from local community laboratories.
Topics: Adolescent; Adult; Anti-Infective Agents, Urinary; Drug Resistance; Escherichia coli Infections; Fem | 2002 |
Secretion of various antimicrobial substances in dogs with experimental bacterial prostatitis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Dogs; Doxycycline; Drug Evaluation, Preclinical; Erythro | 1977 |
Trimethoprim-resistant coliforms.
Topics: Cross Infection; Drug Combinations; Drug Resistance, Microbial; England; Escherichia coli; Escherich | 1977 |
Chromosomal resistance to trimethoprim.
Topics: Escherichia coli; Escherichia coli Infections; Humans; R Factors; Trimethoprim; Urinary Tract Infect | 1978 |
Long-term therapy of chronic bacterial prostatitis with trimethoprim-sulfamethoxazole.
Topics: Acinetobacter Infections; Administration, Oral; Adult; Aged; Bacterial Infections; Body Fluids; Drug | 1975 |
[Successful poteceptil treatment of endocarditis caused by E. coli].
Topics: Adult; Endocarditis, Bacterial; Escherichia coli Infections; Humans; Male; Sulfamethazine; Trimethop | 1977 |
Breeding record analysis in pig herds and its veterinary applications--2: Experiences with a large commercial unit.
Topics: Abscess; Animals; Bordetella Infections; Breeding; Computers; Diarrhea; Escherichia coli Infections; | 1977 |
Serum antibody titers in treatment with trimethoprim-sulfamethoxazole for chronic prostatitis.
Topics: Adult; Antibodies, Bacterial; Chronic Disease; Drug Combinations; Escherichia coli; Escherichia coli | 1978 |
Antibacterial prophylaxis in patients after prostatectomy.
Topics: Aged; Bacterial Infections; Chloramphenicol; Enterobacteriaceae Infections; Escherichia coli Infecti | 1977 |
[Comparison of the kinetics of bactericidal action in vitro of sulfametrol and sulfamethoxazol, alone and in combination with trimethoprim (author's transl)].
Topics: Drug Combinations; Escherichia coli; Escherichia coli Infections; In Vitro Techniques; Kinetics; Sta | 1978 |
Trimethoprim in combination with a sulfonamide for oral treatment of canine urinary tract infections.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Drug Therapy, Combination; Escherichia coli Infec | 1979 |
Treatment of malakoplakia with trimethoprim-sulfamethoxazole.
Topics: Adult; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Malacoplakia; Retrope | 1979 |
[Gentamycin and biseptol-480 in the colibacillosis of calves].
Topics: Animals; Animals, Newborn; Cattle; Cattle Diseases; Drug Combinations; Drug Evaluation; Escherichia | 1979 |
Susceptibility of Escherichia coli K1 to four combinations of antimicrobial agents potentially useful for treatment of neonatal meningitis.
Topics: Ampicillin; Anti-Bacterial Agents; Cefamandole; Cerebrospinal Fluid; Chloramphenicol; Drug Combinati | 1979 |
Intravenous trimethoprim-sulfamethoxazole in the treatment of serious infections in children.
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Escherichia co | 1979 |
Efficacy of two trimethoprim-sulphonamide combinations in experimental pyelonephritis in the rat.
Topics: Animals; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Escherichia coli I | 1979 |
[The bioavailability and clinical efficay of drylin, a new drug combination of TMP/SMZ].
Topics: Bacillus subtilis; Biological Availability; Drug Combinations; Drug Evaluation; Drug Resistance, Mic | 1977 |
The resistance of 150 Klebsiella and E. coli strains isolated from patients suffering from bacteriaemia.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistanc | 1976 |
Data on the pharmacokinetics of sulfonamid-trimethoprim Combinations in sucking pigs.
Topics: Animals; Animals, Newborn; Drug Combinations; Escherichia coli Infections; Kinetics; Sulfonamides; S | 1976 |
Treatment of meningitis and septicemia in infancy with a sulphamethoxazole/trimethorpim combination.
Topics: Ampicillin; Anemia, Hypochromic; Body Weight; Drug Synergism; Drug Therapy, Combination; Escherichia | 1975 |
The diffusion and concentration of trimethoprim in human vaginal fluid.
Topics: Adult; Bacteriuria; Body Fluids; Diffusion; Dose-Response Relationship, Drug; Enterobacteriaceae; En | 1975 |
Prophylactic chemotherapy with low-dosage trimethoprim-sulfamethoxazole following acute urinary tract infections in children.
Topics: Ampicillin; Bacterial Infections; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Esche | 1975 |
Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
Topics: Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae Infections; Escherichia coli; Esch | 1975 |
Editorial: A clinical classification of urinary tract infections based upon origin.
Topics: Bacteriuria; Chronic Disease; Escherichia coli Infections; Female; Humans; Male; Methenamine; Nitrof | 1975 |
The use of co-trimoxazole in sulphonamide-resistant Escherichia coli urinary tract infection.
Topics: Culture Media; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Escherichia coli; Esch | 1975 |
Bowel flora in urinary tract infection: effect of chemotherapy with special reference to cotrimoxazole.
Topics: Anti-Infective Agents, Urinary; Child; Drug Combinations; Drug Resistance, Microbial; Escherichia co | 1975 |
Spread of a newly found trimethoprim resistance gene, dhfrIX, among porcine isolates and human pathogens.
Topics: Animals; Base Sequence; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Genes, Ba | 1992 |
Trimethoprim/sulfamethoxazole remains active against enterotoxigenic Escherichia coli and Shigella species in Guadalajara, Mexico.
Topics: Diarrhea; Drug Resistance, Microbial; Dysentery, Bacillary; Escherichia coli Infections; Humans; Mex | 1992 |
Cardiac output and organ blood flow in experimental septic shock: effect of treatment with antibiotics, corticosteroids, and fluid infusion.
Topics: Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Cardiac Output; Escherichia coli Infections | 1991 |
MICs of ciprofloxacin and trimethoprim for Escherichia coli: influence of pH, inoculum size and various body fluids.
Topics: Animals; Body Fluids; Chronic Disease; Ciprofloxacin; Dogs; Dose-Response Relationship, Drug; Escher | 1991 |
Parenteral amoxycillin/clavulanate in the treatment of diarrhoea in young pigs.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Clavulanic Acids; Diarrhea; Dru | 1990 |
Faecal Escherichia coli mediating transferable multi-antibiotic resistance and undesirable extra-chromosomal genes.
Topics: Acute Disease; Ampicillin; Child; Diarrhea; DNA, Bacterial; Escherichia coli; Escherichia coli Infec | 1986 |
Myocardial abscess after silent myocardial infarction.
Topics: Abscess; Aged; Combined Modality Therapy; Drug Combinations; Endocarditis, Bacterial; Escherichia co | 1989 |
In vivo efficacy of zidovudine (3'-azido-3'-deoxythymidine) in experimental gram-negative-bacterial infections.
Topics: Ampicillin; Animals; Bacterial Infections; Cattle; Escherichia coli Infections; Female; Gram-Negativ | 1989 |
Ascending pyelonephritis in young rats retards kidney growth.
Topics: Aging; Animals; Body Weight; DNA; Drug Combinations; Escherichia coli Infections; Female; Glomerular | 1989 |
Secondary infections in dracunculiasis: bacteria and morbidity.
Topics: Cefotaxime; Dracunculiasis; Drug Combinations; Enterobacter; Enterobacteriaceae Infections; Escheric | 1985 |
Trimethoprim resistance of Escherichia coli in outpatients in Finland after ten years' use of plain trimethoprim.
Topics: DNA Transposable Elements; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections | 1985 |
[Single day treatment in acute cystitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Cystitis; | 1988 |
Effects of single-dose and three-day trimethoprim-sulfadiazine and amikacin treatment of induced Escherichia coli urinary tract infections in dogs.
Topics: Amikacin; Animals; Anti-Infective Agents, Urinary; Bacteriuria; Dog Diseases; Dogs; Drug Administrat | 1988 |
Effect of hyperbaric oxygenation, combined with antimicrobial agents and surgery, in a rat model of intraabdominal infection.
Topics: Abdomen; Abscess; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Dise | 1988 |
Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin.
Topics: Ampicillin; Ampicillin Resistance; Anti-Infective Agents, Urinary; Drug Combinations; Drug Resistanc | 1988 |
Trimethoprim-resistant Shigella and enterotoxigenic Escherichia coli strains in children in Thailand.
Topics: Anti-Bacterial Agents; Child; Conjugation, Genetic; Diarrhea; DNA, Bacterial; Drug Combinations; Dys | 1987 |
[Experimental cystitis in the rat and the therapeutic effect of a single dose of fosfomycin trometamol].
Topics: Animals; Cystitis; Drug Combinations; Drug Evaluation, Preclinical; Escherichia coli Infections; Fos | 1987 |
Acute lobular nephronia.
Topics: Acute Disease; Drug Combinations; Escherichia coli Infections; Female; Focal Infection; Humans; Male | 1986 |
Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease.
Topics: Cysts; Drug Combinations; Drug Evaluation; Drug Synergism; Escherichia coli; Escherichia coli Infect | 1986 |
Intrafamilial spreading of Escherichia coli resistant to trimethoprim.
Topics: Adolescent; Adult; Carrier State; Child; Child, Preschool; Drug Resistance, Microbial; Escherichia c | 1986 |
Benefit from high intrarenal levels of gentamicin in the treatment of E. coli pyelonephritis.
Topics: Acute Disease; Ampicillin; Animals; Cephalothin; Drug Evaluation, Preclinical; Drug Synergism; Drug | 1986 |
Trimethoprim and methenamine hippurate. A new theoretical combination for the treatment of urinary tract infections.
Topics: Adult; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infec | 1985 |
Kelfiprim. A new sulfa-trimethoprim combination in urinary tract infections.
Topics: Adult; Aged; Drug Combinations; Escherichia coli Infections; Female; Humans; Klebsiella Infections; | 1985 |
[Contamination of the small intestine as a cause for ileus attacks in children after intestinal surgery].
Topics: Child; Child, Preschool; Clostridium; Clostridium Infections; Drug Combinations; Escherichia coli; E | 1985 |
[Therapeutic aspects of coli mastitis in ruminants].
Topics: Animals; Cattle; Chloramphenicol; Drug Evaluation, Preclinical; Escherichia coli Infections; Female; | 1985 |
Norfloxacin versus trimethoprim-sulphamethoxazole: efficacy in a model of ascending urinary tract infection in normal and streptozotocin-induced diabetic mice.
Topics: Animals; Anti-Infective Agents; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Combin | 1985 |
[Kidney function and bacteriological and histological research in the therapy of experimental E. coli pyelonephritis using trimethoprim-sulfamethoxazole (TMP-SMO)].
Topics: Animals; Drug Combinations; Drug Evaluation, Preclinical; Escherichia coli Infections; Half-Life; Io | 1985 |
[Antibiotic susceptibility of E. coli strains isolated from urinary tract infections and the role of metabolically deficient strains in these infections].
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; | 1985 |
The resistance to anti-microbial agents of bacteria isolated from pathological conditions of birds in Victoria, 1978 to 1983.
Topics: Animals; Anti-Bacterial Agents; Bird Diseases; Birds; Drug Resistance, Microbial; Escherichia coli I | 1985 |
Trimethoprim-resistant coliforms.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Combinations; Drug Resistance, Microbial; Enterobacteriacea | 1972 |
[Models of urinary infection].
Topics: Animals; Bacterial Infections; Bacteriuria; Carbenicillin; Disease Models, Animal; Drug Therapy, Com | 1974 |
The use of trimethoprim-sulphamethoxazole in urinary tract infections in domiciliary practice.
Topics: Anti-Infective Agents; Bacteriuria; Child, Preschool; Chronic Disease; Drug Eruptions; Escherichia c | 1973 |
Trimethoprim sulfamethoxazole therapy of chronic bacterial prostatitis.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Candidiasis, Oral; Child; Drug Eruptions; Escherichia | 1974 |
Escherichia coli in urinary tract infections in Sudanese patients.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Drug Combinations; Escherichia coli; Escherichia | 1972 |
The diagnosis and management of bacterial prostatitis.
Topics: Acute Disease; Bacterial Infections; Bacteriuria; Chronic Disease; Escherichia coli; Escherichia col | 1972 |
Trimethoprim-sulfamethoxazole in children: pharmacokinetics and clinical studies.
Topics: Anemia, Aplastic; Anemia, Sickle Cell; Bacterial Infections; Child; Child, Preschool; Drug Combinati | 1973 |
Trimethoprim-sulfamethoxazole in recurrent urinary tract infection in children.
Topics: Child; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Male; Proteus Inf | 1973 |
Prostatitis. Observations on activity of trimethoprim-sulfamethoxazole in the prostate.
Topics: Adult; Bacterial Infections; Chronic Disease; Drug Combinations; Escherichia coli Infections; Humans | 1973 |
R factors in Enterobacteriaceae causing urinary-tract infection in general practice in 1962-63 and 1968-69.
Topics: Ampicillin; Chloramphenicol; Escherichia coli; Escherichia coli Infections; Family Practice; Humans; | 1973 |
Cerebrospinal fluid cotrimoxazole levels.
Topics: Cerebral Ventricles; Drug Combinations; Escherichia coli Infections; Humans; Hydrocephalus; Infant; | 1974 |
Letter: Co-trimoxazole resistance.
Topics: Culture Media; Drug Resistance, Microbial; Escherichia coli Infections; Humans; Sulfamethoxazole; Tr | 1974 |
Ampicillin versus trimethoprim sulfamethoxazole in chronic urinary tract infection.
Topics: Adult; Aged; Ampicillin; Bacterial Infections; Chronic Disease; Enterobacteriaceae Infections; Esche | 1974 |
Trimethoprim-sulfamethoxazole compared with sulfamethoxazole in urinary tract infection.
Topics: Adult; Aged; Drug Combinations; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Recu | 1974 |
[Antibacterial chemotherapy of the chronic bronchitis syndrome].
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Carbenicillin; Cephalosporins; | 1974 |
Thymine-requiring Escherichia coli mutants isolated from animals. An unusual type of resistance to trimethoprim.
Topics: Animals; Cattle; Cattle Diseases; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Inf | 1974 |
Letter: Trimethoprim-sulfamethoxazole in urinary tract infection.
Topics: Drug Therapy, Combination; Escherichia coli Infections; Humans; Sulfamethoxazole; Trimethoprim; Urin | 1974 |
Trimethoprim-sulphamethoxazole treatment in staphylococcal endocarditis and gram-negative septicemia.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteriological Techniques; Drug Combinations; Electroc | 1974 |
Thymidine-dependent Escherichia coli infection and some associated laboratory problems.
Topics: Adult; Aged; Ampicillin; Blood; Culture Media; Drug Combinations; Escherichia coli; Escherichia coli | 1974 |
[Treatment of E. coli enteritis in newborn calves with sulfachloropyridazine-trimethoprim combination].
Topics: Animals; Animals, Newborn; Cattle; Cattle Diseases; Drug Therapy, Combination; Enteritis; Escherichi | 1974 |
[Short-term therapy of urinary tract infections with a combination of trimethoprim and sulfamethoxazole].
Topics: Adult; Aged; Anti-Infective Agents; Bacteriuria; Drug Synergism; Escherichia coli Infections; Female | 1971 |
An improved synthesis of diaveridine, trimethoprim, and closely related 2,4-diaminopyrimidines.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Drug Synergism; Escherichia coli Infections; K | 1971 |
[Experiences with trimethoprim-sulfamethoxazole in the chemotherapy of bacterial infections].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bacteriuria; Bronchiectasis; B | 1970 |
[Trimethoprim and sulfamethoxazole (Eusaprim) in chronic urinary tract infections].
Topics: Aged; Anti-Bacterial Agents; Chronic Disease; Escherichia coli; Escherichia coli Infections; Folic A | 1971 |
Long-term trimethoprim-sulphamethoxazole in the management of recurrent urinary infection.
Topics: Anti-Infective Agents; Drug Combinations; Escherichia coli Infections; Female; Folic Acid Antagonist | 1971 |
Extended therapy with a trimethoprim-sulphonamide for the treatment of established urinary tract infection.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Drug Combinations; Drug Hypersensitivity; Escherichi | 1971 |